Odor-No-More was Biolargo’s largest segment in fiscal 2025, bringing in $5.91M of $7.77M (76%).
| Segment | FY 2017 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|
| Odor-No-More | $4.37M | $11.44M | $15.60M | $5.91M | ||||
| Biolargo Engineering, Science & Technologies, Llc | $1.94M | $2.40M | $3.20M | $2.55M | ||||
| Clyra | $56.00K | $20.00K | — | — | ||||
| Biolargo Canada | $1.00K | $30.00K | $72.00K | $86.00K | ||||
| Biolargo Water | — | — | — | — | ||||
| Corporate, Non-Segment | $5.00K | — | — | — | ||||
| Consolidation, Eliminations | -$495.00K | -$1.66M | -$1.09M | -$771.00K | ||||
| Total | $5.88M | $12.23M | $17.78M | $7.77M |
Biolargo brought in $7.77M from its four segments in fiscal 2025, the year ended December 31, 2025. That was down 56.3% from $17.78M in fiscal 2024. Odor-No-More was the largest at $5.91M (76.0%), ahead of Biolargo Engineering, Science & Technologies, Llc at $2.55M (32.8%) and Biolargo Canada at $86.00K (1.1%).
Compared with fiscal 2024, Biolargo Engineering, Science & Technologies, Llc fell 20.4% to $2.55M and Odor-No-More fell 62.1% to $5.91M.
Biolargo stopped reporting Clyra ($20.00K in fiscal 2023) and Corporate, Non-Segment ($5.00K in fiscal 2022) as separate segments. The total is net of Consolidation, Eliminations, which took $771.00K off revenue in fiscal 2025.
Product was Biolargo’s largest product and service line in fiscal 2025, bringing in $5.77M of $7.77M (74%).
| Product and Service | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Product | $4.43M | $11.46M | $16.76M | $5.77M | |||||
| Service | $1.45M | $770.00K | $1.02M | $2.00M | |||||
| Total | $5.88M | $12.23M | $17.78M | $7.77M |
Biolargo brought in $7.77M from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That was down 56.3% from $17.78M in fiscal 2024. Product was the largest at $5.77M (74.3%), ahead of Service at $2.00M (25.7%).
Compared with fiscal 2024, Service grew 96.5% to $2.00M, while Product fell 65.6% to $5.77M. From fiscal 2022 to 2025, combined revenue from these lines grew from $5.88M to $7.77M, a compound annual growth rate of 9.7%. Product's share of the total fell from 75.4% to 74.3%.
Biolargo (BLGO) reports its revenue by segment and by product and service. In fiscal 2025, Odor-No-More was its largest segment, bringing in $5.91M (76.0% of the total), followed by Biolargo Engineering, Science & Technologies, Llc at $2.55M (32.8%).
Odor-No-More was Biolargo's largest segment in fiscal 2025, bringing in $5.91M, or 76.0% of the $7.77M total across its four segments.
Product was Biolargo's largest product and service line in fiscal 2025, bringing in $5.77M, or 74.3% of the $7.77M total across its two product and service lines.
Service grew faster than Product in fiscal 2025, up 96.5% from $1.02M to $2.00M. Product fell 65.6% to $5.77M.
Every figure comes from Biolargo's annual financial filings, as reported. Each line keeps the name Biolargo gives it, and years follow its fiscal calendar.
Biolargo's revenue by segment goes back to fiscal 2017, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.